Pathobiology Awards
Explore details about the focus, goals, methods, and findings of individual RECOVER pathobiology studies.
66 Results
66 Results
ROA2023Adult
Molecular Determination of Risk for PASC by High Sensitivity Serological Analyses of Inflammatory Pathway Markers, Prior Viral Histories and Autoantibodies
David Walt, Brigham and Women's Hospital
ROA2023Pediatric
Neurological Sequelae Associated with Post-Acute SARS-CoV-2 Infection (NEURO-PASC)
Amy Salisbury, Virginia Commonwealth University
ROA2023
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2 infection and Inflammation in Human Adipose Tissue
Catherine Blish, Stanford University
ROA2023
Origins of Post-Acute Sequelae SARS-CoV-2 Infection (PASC) Lung Fibrosis
Amit Gaggar, University of Alabama at Birmingham
ROA2023Adult
Pathophysiological Mechanisms of PASC: Inflammatory Mediators of Endothelial Dysfunction in the RECOVER Cohort
Ellen Kraig, The University of Texas Health Science Center at San Antonio
ROA2023Adult
Post Acute Sequelae of COVID-19 (PASC) Investigators Consortium Phase 2: Researching COVID to Enhance Recovery (RECOVER)
Lawrence Kleinman, Rutgers Biomedical and Health Sciences, Robert Wood Johnson Medical School
ROA2023
Prenatal Immune Activation and Maternal Mental Health as Predictors of Infant Sleep and Cognitive Development
Moriah Thomason, New York University Grossman School of Medicine
ROA2023Adult
Sleep Disturbance Compromises Adaptive and Innate Immune Indices in Long COVID: T-cell Responses to SARS-CoV-2 Variants, Activation of Pro-inflammatory and Pro-resolving Pathways, and Glucocorticoid Sensitivity
Monika Haack, Beth Israel Deaconess Medical Center